Search Results 2661-2670 of 19152 for Chiari malformation

  1. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

    ... syndrome/expert-answers/narrow-stools/faq-20057781</loc><lastmod>2024-11-04T18:34:45-06:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https ...

  2. Psychotherapy - Doctors & Departments - Mayo Clinic

    DiGeorge syndrome (22q11.2 deletion syndrome) · Dissociative disorders · Dizziness · Encephalitis · Encopresis · Factitious disorder · Generalized anxiety ...

  3. Transient ischemic attack (TIA) - Doctors and departments - Mayo Clinic

    ... malformations, ...CNS vasculitis, Arteriovenous malformation, Central nervous system vascular malformations. Show more areas of focus for Robert D. Brown, Jr ...

  4. Testing The Use Of The Combination Of Selumetinib And Olaparib Or Selumetinib Alone Targeted Treatment For RAS Pathway Mutant Recurrent Or Persistent Ovarian And Endometrial Cancers, A ComboMATCH Treatment Trial - Mayo Clinic

    - Known myelodysplastic syndrome/acute myeloid leukemia or with features suggestive of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) - ...

  5. Congenital diaphragmatic hernia (CDH) - CON-20472981-Symptoms and causes - Mayo Clinic

    In CDH, a baby's diaphragm — the muscle that separates the chest from the abdomen — develops a hole called a hernia. Learn about treatment before birth.

  6. Surgery - Clinical trials

    A Study to Assess Long-term Symptom Improvement and Recurrence after Operative Management of Popliteal Artery Entrapment Syndrome (PAES). Rochester, Minn ...

  7. Neurology - Clinical trials

    This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). ... abnormalities in ALS we aim to ...

  8. Neurology - Clinical trials - Mayo Clinic

    ... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...

  9. Neurology - Clinical trials

    ... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...

  10. Neurology - Clinical trials - Mayo Clinic

    This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). ... abnormalities in ALS we aim to ...